AONC Logo

American Oncology Network, Inc. (AONC) 

NASDAQ
Market Cap
$127.35M
Sector
Healthcare
Industry
Medical—Care Facilities
Rank in Sector
371 of 958
Rank in Industry
15 of 45

Largest Insider Buys in Sector

AONC Stock Price History Chart

AONC Stock Performance

About American Oncology Network, Inc.

American Oncology Network, Inc., through its subsidiaries, provides oncology services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance. The company was incorporated in 2017 …

Insider Activity of American Oncology Network, Inc.

Over the last 12 months, insiders at American Oncology Network, Inc. have bought $20,712 and sold $0 worth of American Oncology Network, Inc. stock.

On average, over the past 5 years, insiders at American Oncology Network, Inc. have bought $20,712 and sold $2.16M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Divers Stephen (Chief Medical Officer) — $10,750. Schonherz Todd (Chief Executive Officer) — $9,962.

The last purchase of 5,000 shares for transaction amount of $10,750 was made by Divers Stephen (Chief Medical Officer) on 2024‑05‑24.

List of Insider Buy and Sell Transactions, American Oncology Network, Inc.

2024-05-24PurchaseChief Medical Officer
5,000
0.0059%
$2.15$10,750+52.58%
2024-05-21PurchaseChief Executive Officer
5,340
0.0055%
$1.87$9,962+88.82%
2023-09-25Sale10 percent owner
205,512
1.1821%
$10.50$2.16M-69.69%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.